RB1 and hepatocellular carcinoma: The significant downregulation of the Rb protein increases the vulnerability of hepatocellular carcinoma (HCC) cells to ferroptosis and the efficacy of sorafenib, indicating that the loss of the Rb gene accelerates the progression of ferroptosis (289).